| ORGN | Tuesday, August 18, 2009 | ||
1:30 PM-4:45 PM Walter E. Washington Convention Center -- 207A, Oral | |||
Small Molecule Therapeutic Agents | |||
| Sponsored by: | ORGN | ||
| Cosponsored by: | MEDI | ||
| Organizer: | Sanjay V. Malhotra | ||
| 1:30 PM | 367 | Targeting COX-2 for cancer prevention and therapy Lawrence J Marnett | |
| 2:00 PM | 368 | National Cancer Institute's Chemical Biology Consortium: An academic/public partnership for the discovery of novel cancer therapeutics James H. Doroshow | |
| 2:30 PM | 369 | Identification and characterization of novel, potent, and selective inhibitors of protein kinase D. Elizabeth R. Sharlow, Peter Wipf, Q. Jane Wang, John S. Lazo | |
| 3:00 PM | Intermission | ||
| 3:15 PM | 370 | DNA methyltransferase as a therapeutic target Moshe Szyf | |
| 3:45 PM | 371 | Targeting historically refractory interfaces: In silico discovery of small molecules targeting transcription factors in cancer and inflammation Alan C Rigby, Kumaran Shanmugasundaram | |
| 4:15 PM | 372 | Chemistry and biology of spliceostatin A: An antitumor agent that inhibits pre-mRNA splicing Minoru Yoshida, Ryohei Furumai, Daisuke Kaida | |
Previous Session -- Small Molecule Therapeutic Agents -- Next Session
Symposium Grid -- Division of Organic Chemistry -- Session Listing
The 238th ACS National Meeting, Washington, DC, August 16-20, 2009